| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.059 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |